Literature DB >> 32303402

No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency.

A G Andersen1, M C Ørngreen2, D E T Raaschou-Pedersen2, J de Stricker Borch2, N Løkken2, T O Krag2, M B Petersen3, J Vissing2.   

Abstract

This case report investigated exercise metabolism and the effect of oral sucrose and intravenous glucose supplementation in a 30-year-old, mildly affected man with muscle phosphorylase b kinase (PHK) deficiency caused by a novel c.586G>A mutation in the PHKA1 gene. Only 12 patients with PHK deficiency have been reported and it is unclear to what extent patients exhibit symptoms during exercise. Carbohydrate and fat metabolism were measured during 30 min of exercise at ∼ 70% of peak oxidative capacity using stabile isotope technique and signaling proteins and enzymes in the energy pathway were analyzed by Western blot. Results were compared to four healthy subjects. These studies show that neither oral nor intravenous glucose improved exercise tolerance in this patient with PHK deficiency. Despite Western blots indicated affected metabolism on protein level, systemic substrate turnover studies showed that carbohydrate and fatty acid oxidations were normal.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbohydrate and fat metabolism; Glycogen storage disease; Muscle Glycogenosis; Muscle phosphorylase kinase deficiency

Mesh:

Substances:

Year:  2020        PMID: 32303402     DOI: 10.1016/j.nmd.2020.02.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

Review 1.  A century of exercise physiology: key concepts in regulation of glycogen metabolism in skeletal muscle.

Authors:  Abram Katz
Journal:  Eur J Appl Physiol       Date:  2022-03-30       Impact factor: 3.346

2.  Expanding the clinicopathological-genetic spectrum of glycogen storage disease type IXd by a Chinese neuromuscular center.

Authors:  Kun Huang; Hui-Qian Duan; Qiu-Xiang Li; Yue-Bei Luo; Fang-Fang Bi; Huan Yang
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.